Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

Recent & Breaking News (TSX:EDT)

Spectral Medical (TSX:EDT) receives FDA approval for DIMI trial protocol amendment

Caroline Egan  January 31, 2022

Spectral Medical Announces U.S. FDA Approval of DIMI Trial Protocol Amendment

GlobeNewswire January 31, 2022

Spectral to Present at the SNN Network Canada Virtual Event on Wednesday, December 8, 2021

GlobeNewswire December 3, 2021

Spectral Medical Schedules Conference Call to Provide Clinical Update and Discuss Latest Developments

GlobeNewswire November 30, 2021

Spectral Medical Announces U.S. FDA Approval of Tigris Trial Protocol Amendment to Expand Inclusion Criteria

GlobeNewswire November 29, 2021

Spectral to Present at the Q4 Investor Summit on November 16th

Newsfile November 15, 2021

Spectral Announces Third Quarter Results and Provides Corporate Update

GlobeNewswire November 12, 2021

Spectral to Present at the Benzinga Global Small Cap Conference on October 27, 2021

GlobeNewswire October 25, 2021

Spectral and Dialco Announce Dr. John Kellum to Be Featured as Keynote Lecturer at the 39th Vicenza Course on AKI and CRRT

GlobeNewswire October 20, 2021

Spectral Medical's CMO Recognized as a World Expert in Sepsis; Supports World Sepsis Day and Sepsis Awareness Month

GlobeNewswire September 13, 2021

Spectral Medical Announces its Participation at Upcoming Investor Conferences

GlobeNewswire August 23, 2021

Spectral Announces Second Quarter Results and Provides Corporate Update

GlobeNewswire August 13, 2021

Spectral Medical Announces Internal Reorganization of its Wholly Owned Subsidiary Dialco Medical to Enhance Operations and Accelerate Commercialization

GlobeNewswire August 9, 2021

Spectral Medical Inc. (TSX:EDT) provides Tigris clinical trial update

Brieanna McCutcheon  July 28, 2021

Spectral Medical Inc. Provides Tigris Clinical Trial Update

GlobeNewswire July 28, 2021

Spectral Medical Closes $10M Bought-Deal Offering

John Ballem  July 27, 2021

Spectral Medical Inc. Closes $10 Million Offering of Units

GlobeNewswire July 27, 2021

Spectral Medical (TSX:EDT) announces $10 million offering

Trevor Abes  July 21, 2021

Spectral Medical Inc. Announces $10 Million Offering

GlobeNewswire July 21, 2021

Spectral Medical Inc. Announces Overnight Marketed Offering

GlobeNewswire July 20, 2021